TY - JOUR T1 - A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase JO - Oncotarget UR - https://eprints.whiterose.ac.uk/119393/ PY - 2015/11/22 AU - Sakurikar N AU - Thompson R AU - Montano R AU - Eastman A ED - DO - DOI: 10.18632/oncotarget.6364 VL - 7 IS - 2 SP - 1380 EP - 1394 Y2 - 2025/04/08 ER -